000			05687cam a2200769Ii 4500
001			ocn953456125
003			OCoLC
005			20221128213040.0
006			m d
007			cr cnu|||unuuu
008			160712s2016 enkaf ob 001 0 eng d
040			_aN$T _beng _erda _epn _cN$T _dYDXCP _dEBLCP _dN$T _dOCLCF _dUKOUP _dOCLCQ _dWRM _dCUV _dOCLCO _dOCLCQ _dOCLCA _dOCLCQ _dUKAHL _dOCLCQ _dOCLCO
019			_a945028029
020			_a9780191045431 _q(electronic bk.)
020			_a0191045438 _q(electronic bk.)
020			_a9780191795909 _q(electronic bk.)
020			_a0191795909 _q(electronic bk.)
020			_z9780198729204
020			_z0198729200
035			_a1244380 _b(N$T)
035			_a(OCoLC)953456125 _z(OCoLC)945028029
060		4	_aWE 550
072		7	_aHEA _x039000 _2bisacsh
072		7	_aMED _x014000 _2bisacsh
072		7	_aMED _x022000 _2bisacsh
072		7	_aMED _x112000 _2bisacsh
072		7	_aMED _x045000 _2bisacsh
049			_aMAIN
245	0	0	_aPolymyalgia rheumatica and giant cell arteritis _c _h[E-Book]
250			_aFirst edition.
264		1	_aOxford, United Kingdom : _bOxford University Press, _c2016.
300			_a1 online resource : _billustrations
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
490	1		_aOxford rheumatology library
588	0		_aPrint version record.
504			_aIncludes bibliographical references and index.
588	0		_aOnline resource; title from PDF title page (EBSCO, viewed September 12, 2016).
505	0		_aCover; Polymyalgia Rheumatica and Giant Cell Arteritis; Copyright; Contents; Abbreviations; Contributors; Plates; Part 1 Epidemiology, pathogenesis, and clinical presentation; 1 Definition and epidemiology; 2 Aetiology and pathogenesis; 3 Clinical presentation and classification criteria for polymyalgia rheumatica; 4 Clinical manifestations of giant cell arteritis; Part 2 Diagnostic work-up; 5 Laboratory findings; 6 Ultrasound; 7 Temporal artery biopsy; 8 Positron emission tomography and magnetic resonance imaging; 9 Differential diagnosis; Part 3 Guidelines for treatment; 10 Glucocorticoids.
505	8		_a11 Role of steroid-sparing agents12 Treatment of a relapse and approach to difficult-to-treat patients; 13 Management of sight loss and other disease- and treatment-related complications; Part 4 Outcomes, prognosis, socioeconomic implications, primary care, and patient perspectives; 14 Determination of disease activity and outcomes; 15 Prognosis and duration of therapy; 16 Primary care; 17 Socioeconomic implications; 18 Patient education; Index.
520			_aPart of the Oxford Rheumatology Library series, Polymyalgia Rheumatica and Giant Cell Arteritis provides quick and practically relevant information on several aspects of the diseases, particularly on diagnosis and management, with the ultimate aim of improving the patient's care.
520			_aPolymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are related conditions occurring almost exclusively in older people. Polymyalgia rheumatica is considered to be the rheumatic disease that is subject to the widest variations of clinical practice, partially due to the considerable uncertainty related to diagnosis and outcomes. Giant cell arteritis, an inflammatory form of vasculitis, may present with a broad spectrum of clinical manifestations and can be complicated by acute ischemic events, the most serious of which is permanent blindness. Early recognition and adequate treatment of the condition is thus necessary to prevent patients' loss of independence and to maintain their quality of life. Part of the Oxford Rheumatology Library series, Polymyalgia Rheumatica and Giant Cell Arteritis provides quick and practically relevant information on several aspects of the diseases, particularly on diagnosis and management, with the ultimate aim of improving the patient's care. Chapters highlight current concepts of pathogenesis, recent advances of diagnostic and therapeutic approaches, and the ongoing research into the identification of new biomarkers and corticosteroid-sparing medications. Each chapter is complemented with key message boxes highlighting the most relevant information for clinical practice. This concise but comprehensive reference is particularly suited for rheumatologists, general practitioners, and other professionals caring for patients with PMR and GCA.
590			_aWorldCat record variable field(s) change: 650
650		0	_aPolymyalgia rheumatica.
650		0	_aGiant cell arteritis.
650		0	_aOutcome assessment (Medical care)
650	1	2	_aPolymyalgia Rheumatica _xdiagnosis
650	2	2	_aPolymyalgia Rheumatica _xtherapy
650	2	2	_aGiant Cell Arteritis _xdiagnosis
650	2	2	_aGiant Cell Arteritis _xtherapy
650	2	2	_aTreatment Outcome
650		2	_aPolymyalgia Rheumatica
650		2	_aGiant Cell Arteritis
700	1		_aD�a�sagupta, Bhaskara, _eeditor.
700	1		_aDejaco, Christian, _eeditor.
830		0	_aOxford rheumatology library.
856	4	0	_uhttps://search.ebscohost.com/login.aspx?custid=ns123844&authtype=ip,shib&direct=true&scope=site&db=nlebk&db=nlabk&AN=1244380 _yKingston Hospital NHS Foundation Trust OpenAthens account holders click here for access
938			_aAskews and Holts Library Services _bASKH _nAH32985001
938			_aEBL - Ebook Library _bEBLB _nEBL4545382
938			_aEBSCOhost _bEBSC _n1244380
938			_aOxford University Press USA _bOUPR _nEDZ0001386917
938			_aYBP Library Services _bYANK _n12890407
938			_aYBP Library Services _bYANK _n13068020
942			_n0
994			_a92 _bN$T
999			_c92409 _d92409